LEADER 00918nam0-22003131i-450 001 990004642460403321 005 20240129094350.0 035 $a000464246 035 $aFED01000464246 035 $a(Aleph)000464246FED01 035 $a000464246 100 $a19990604d1935----km-y0itay50------ba 101 0 $aita 105 $ay-------001yy 200 1 $aCivitas dei$estoria degli ideali dell'umanita'$fLionel Curtis$gtraduzione italiana di Ada Prospero 210 $aBari$cLaterza$d1935 215 $aXXXI, 303 p.$d21 cm 225 1 $aBiblioteca di cultura moderna$v275 610 0 $aStoria mondiale 676 $a909 700 1$aCurtis,$bLionel$0184685 702 1$aMarchesini Gobetti,$bAda$f<1902-1968> 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990004642460403321 952 $aCOLL. 40(275)$bBibl.13238$fFLFBC 959 $aFLFBC 996 $aCivitas dei$9554173 997 $aUNINA LEADER 03247nam 2200829z- 450 001 9910557396203321 005 20210501 035 $a(CKB)5400000000041935 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/69436 035 $a(oapen)doab69436 035 $a(EXLCZ)995400000000041935 100 $a20202105d2020 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aIon Channels as Marine Drug Targets 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2020 215 $a1 online resource (134 p.) 311 08$a3-03943-797-6 311 08$a3-03943-798-4 330 $aMarine Drugs is glad to announce its first Special Issue book on "ion channels" related research: Under the great stewardship of the Guest Editor, Dr. Jean-Marc Sabatier, four advanced research articles and three comprehensive review papers were collected in the Special Issue "Ion Channels as Marine Drug Targets". Join us to explore the advanced research outcomes in this field: ?-Conotoxin RgIA and a potent analog, RgIA4, in treatment of pain; botulinum toxin-chitosan nanoparticles in treatment of atrial fibrillation; 27-amino acid (aa)-long ?-conotoxin TxVIA that modulates mammalian CaV3.x; first venomics study of Conus tulipa venom; review on marine toxins targeting Kv1 channels; review on synthetic approaches to zetekitoxin AB; and review on marine natural products and drug resistance in latent tuberculosis. The second edition of this Special Issue is open for submissions, we look forward to your contribution. 606 $aMedicine and Nursing$2bicssc 610 $aantiarrhythmics 610 $abioactives 610 $abotulinum toxin A1 610 $achemotherapy 610 $achitosan nanoparticles 610 $aconantokins 610 $aconotoxin 610 $aconotoxins 2 610 $aConus tulipa 610 $aelectrically induced arrhythmia 610 $aguanidine alkaloid 610 $aintraspecific variation 610 $aion channel modulators 610 $aKv1 610 $alatent TB 610 $amammalian NaV channel 610 $amarine anti-TB compounds 610 $amarine toxins 610 $amodulators 610 $aMTB 610 $anet hunting strategy 610 $aneuropathic pain 610 $anicotinic 610 $anirvana cabal 610 $apaclitaxel 610 $apharmacological models of arrhythmia 610 $apotassium channels 610 $aproteomics 610 $aPZA 610 $asaxitoxin 610 $asea anemone toxins 610 $aselective inhibitor 610 $asponges 610 $aT-type CaV3.2 610 $ataxane 610 $atranscriptomics 610 $aTxVIA 610 $avenomics 610 $avoltage-gated sodium channel 610 $azetekitoxin AB 610 $a?9?10 615 7$aMedicine and Nursing 700 $aSabatier$b Jean-Marc$4edt$01295534 702 $aSabatier$b Jean-Marc$4oth 906 $aBOOK 912 $a9910557396203321 996 $aIon Channels as Marine Drug Targets$93023587 997 $aUNINA